2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Coronary Thrombosis

2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with Coronary Thrombosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abrahamsson, TI; Björkman, JA; Mattsson, CJ; Nerme, VK	1

Other Studies

1 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and Coronary Thrombosis

Article	Year
Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis. Thrombosis research, 2005, Volume: 116, Issue:6 Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidase B2; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Lysine Carboxypeptidase; Male; Plasminogen Activators; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator	2005

Article

Year

Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.

Thrombosis research, 2005, Volume: 116, Issue:6

Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidase B2; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Female; Fibrinolysis; Fibrinolytic Agents; Lysine Carboxypeptidase; Male; Plasminogen Activators; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator

2005